10c target in 12 month , page-56

Page 7 of the AGM shows nearer term revenue drivers with BOTH a global consumer healthcare company & their TGA approved manufacturer.

"In 2013, Imugene has extended its Linguet technology
to the Consumer Healthcare Market with a ’meltlet’ for:
• Vitamins, Supplements and Nutraceuticals
– vitamins specifically vitamin D (development
complete and currently being commercialised),
minerals and herbal ranges;

– In November 2013, Imugene has entered into an
R&D project with a Global Consumer Healthcare
company and their TGA approved manufacturer
(both unnamed for confidentiality and competition
reasons);

– First right of refusal to exclusively license results
and products created;
– Vitamins and supplements industry is big business
in Australia, worth an estimated $1.5bn each year;
– The industry is growing at up to 12% annually."